BlackRock, Inc. 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 62,059 1.400% | -234,129 (-79.05%) | Filing |
| 2024-01-29 3:26 pm Sale | 2023-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 296,188 6.500% | -12,309 (-3.99%) | Filing |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 308,497 6.900% | -335,713 (-52.11%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 644,211 14.400% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 644,211 14.400% | 44,284 (+7.38%) | Filing |
| 2022-01-28 1:54 pm Sale | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 599,927 13.500% | -2,929 (-0.49%) | Filing |
| 2021-05-07 5:09 pm Purchase | 2021-04-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 602,856 14.500% | 300,168 (+99.17%) | Filing |
| 2021-01-28 5:56 pm Purchase | 2020-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 302,689 7.300% | 7,163 (+2.42%) | Filing |